Eisai join Milner Therapeutics Consortium
We are delighted to announce that Eisai have joined the Milner Therapeutics Consortium, which now includes 8 pharma partners. Eisai is a leading global research and development-based pharmaceutical company headquartered in Japan. Eisai’s corporate mission is defined...
Milner Institute illuminated blue for the NHS
The Jeffrey Cheah Biomedical Centre illuminated blue tonight, to honour the incredible work of our NHS. Milner Institute Director Professor Tony Kouzarides said “On behalf of scientists in Cambridge and throughout the UK, we thank NHS staff for their selfless...
Milner seminars move online
We have been busy adapting plans for the coming months, and are pleased to announce that our Milner seminars are moving online. The first talk is from Mathew Garnett, and we hope you will join us online for this! Dr Mathew Garnett (Wellcome Sanger Institute)...
A look inside the institute
For the past four years, the Milner Therapeutics Institute has been incubating in the Gurdon Institute – home to the research lab of our Director Tony Kouzarides. This provided essential support as the Milner team was growing and developing key strategic partnerships,...